Qin Gui

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Inflammation and tumor progression: signaling pathways and targeted intervention

Aptamers as targeted therapeutics: current potential and challenges

Pattern recognition receptors: immune targets to enhance cancer immunotherapy

Localized Multi‐Component Delivery Platform Generates Local and Systemic Anti‐Tumor Immunity

2′Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors

Nanotechnology for Multimodal Synergistic Cancer Therapy

N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2

Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways

Pancreatic Cancer–Specific Cell Death Induced In Vivo by Cytoplasmic-Delivered Polyinosine–Polycytidylic Acid